Sprache: Englisch
Verlag: Heartland Psychologists, LLC, 2016
ISBN 10: 0998181811 ISBN 13: 9780998181813
Anbieter: Blue Vase Books, Interlochen, MI, USA
Zustand: very_good. Book has little sign of wear or use.
Hardcover. Zustand: Sehr gut. 1. Auflage. 156 pages with many coloured illustrations.
Anbieter: Bookbot, Prague, Tschechien
Hardcover. Zustand: As New. Leichte Kratzer / Abnutzungen / Druckstellen. Myelodysplastische Syndrome (MDS) und akute myeloische Leukämien (AML) sind keine völlig unabhängigen Krankheitsentitäten, sondern stellen in vielerlei Hinsicht ein biologisches Kontinuum dar.Dieses Buch erläutert in der nun vorliegenden 2. Auflage die pathophysiologischen Grundlagen und stellt die aktuellen Klassifikationen von MDS und AML sowie die prognostischen Systeme dar. Die verschiedenen Behandlungsoptionen wie z.B. Kinase-Inhibition, Angiogenese-Hemmung, Induktionschemotherapie und Stammzelltransplantation sowie die Auswahlkriterien der jeweiligen Therapiemodalitäten werden ausführlich diskutiert.Dieses Lehrbuch vermittelt die Erfahrungen namhafter Experten und ermöglicht einen fundierten Überblick über die aktuellen diagnostischen und therapeutischen Möglichkeiten bei MDS und AML.
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Sprache: Deutsch
Verlag: Mölln, Lauenburgischer Kunstverein,, 1994
Anbieter: Versandantiquariat buch-im-speicher, Berlin, Deutschland
Verbandsmitglied: GIAQ
Zustand: Sehr gut. - Mit zahlreichen, meist farbigen Abb. ; Erschien als Katalog der Ausstellung im Möllner Museum Historisches Rathaus vom 30. Oktober 1994 - 10. Dezember 1994. // Sauberes, frisches Exemplar. Sprache: Deutsch Gewicht in Gramm: 400 4°, 48 S., weißer, farb. illustr. Org.-Brosch.
Sprache: Englisch
Verlag: Heartland Psychologists, LLC, 2016
ISBN 10: 0998181811 ISBN 13: 9780998181813
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 57,76
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 372 pages. 9.25x7.50x0.93 inches. In Stock.
Zustand: New. pp. 246.
hardcover. Zustand: Acceptable. May have underlining, highlighting, margin notes, remainder marks, inscriptions, book plates, tears, significant wear, and/or a missing dust jacket, box, or discs. Damaged item.
Sprache: Deutsch
Verlag: Lauenburgischer Kunstverein, Mölln, 1994
Anbieter: Antiquariat Andreas Schwarz, Bonn, Deutschland
Softcover. Zustand: Sehr gut. 48 S.mit Abbildungen; Original-Karton; Gr.8°. Sehr gutes Exemplar.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 97,90
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,67
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 152,35
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 158,26
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 325 pages. 9.25x6.25x0.75 inches. In Stock.
Sprache: Englisch
Verlag: Springer, Springer Berlin Heidelberg, 2014
ISBN 10: 364238403X ISBN 13: 9783642384035
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 176,70
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Like New. Like New. book.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Epigenetic Therapy of Cancer | Preclinical Models and Treatment Approaches | Michael Lübbert (u. a.) | Taschenbuch | x | Englisch | 2016 | Springer | EAN 9783662519288 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 2016
ISBN 10: 3662519283 ISBN 13: 9783662519288
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.
Anbieter: UK BOOKS STORE, London, LONDO, Vereinigtes Königreich
EUR 224,18
Anzahl: 2 verfügbar
In den WarenkorbZustand: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 269,82
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Like New. Like New. book.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 86,24
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg Jan 2014, 2014
ISBN 10: 364238403X ISBN 13: 9783642384035
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail. 336 pp. Englisch.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 2014
ISBN 10: 364238403X ISBN 13: 9783642384035
Anbieter: moluna, Greven, Deutschland
EUR 89,99
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Devotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathyPresents the latest evidence derived from precli.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 118,26
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Springer, Springer Jan 2014, 2014
ISBN 10: 364238403X ISBN 13: 9783642384035
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 336 pp. Englisch.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg Sep 2016, 2016
ISBN 10: 3662519283 ISBN 13: 9783662519288
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail. 336 pp. Englisch.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 2016
ISBN 10: 3662519283 ISBN 13: 9783662519288
Anbieter: moluna, Greven, Deutschland
EUR 124,20
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Devotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathyPresents the latest evidence derived from precli.